Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CAYSTON safely and effectively. See full prescribing information for CAYSTON. CAYSTON® (aztreonam for inhalation solution), for oral inhalation use Initial U.S. Approval: 1986
Medication labelWhy this: Advisory · dailymed-prescription
CAYSTON® is indicated to improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa. Safety and effectiveness have not been established in pediatric patients below the age of 7 years, patients with FEV1 <25% or >75% predicted, or patients colonized with Burkholderia cepacia [see Clinical Studies (14)]. To reduce the development of drug-resistant bacteria and maintain the effectiveness of CAYSTON and other antibacterial drugs, CAYSTON should be used only to treat patients with CF known to have Pseudomonas aeruginosa in the lungs.
- generic_name
- aztreonam
- brand_name
- sodium chloride
- product_names
- aztreonam, sodium chloride
- ndc
- 61958-0901, 61958-0901-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en